Evidence map›Paper›PMID 34881327›Full record

ArticleERJ open research2021

Granulomatous-lymphocytic interstitial lung disease: an international research prioritisation.

John R Hurst, S Hamza Abbas, Heba M Bintalib, Tiago M Alfaro, Ulrich Baumann, Siobhan O Burns, Alison Condliffe, Jesper R Davidsen, Børre Fevang, Andrew R Gennery and 20 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ERJ open research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

John R HurstUCL Respiratory, University College London, London, UK.ORCID https://orcid.org/0000-0002-7246-6040
S Hamza AbbasUCL Respiratory, University College London, London, UK.
Heba M BintalibUCL Respiratory, University College London, London, UK.ORCID https://orcid.org/0000-0002-3673-5995
Tiago M AlfaroUnit of Pneumology, Coimbra Hospital and Universitary Centre, Coimbra, Portugal.ORCID https://orcid.org/0000-0001-6490-0620
Ulrich BaumannPaediatric Pulmonology, Allergy and Neonatology, Hanover Medical School, Hannover, Germany.
Siobhan O BurnsInstitute of Immunity and Transplantation, University College London, London, UK.
Alison CondliffeDept of Infection, Immunity and Cardiovascular Diseases, University of Sheffield, Sheffield, UK.
Jesper R DavidsenSouth Danish Centre for Interstitial Lung Diseases (SCILS), Dept of Respiratory Medicine, Odense University Hospital, Odense, Denmark.ORCID https://orcid.org/0000-0003-4128-4014
Børre FevangSection of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Oslo, Norway.
Andrew R GenneryTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Filomeen HaerynckDept of Pediatric Pulmonology and Immunology, Jeffrey Modell Foundation Diagnostic and Research Centre, PID Research lab, Ghent University Hospital, Ghent University, Ghent, Belgium.
Joseph JacobUCL Respiratory, University College London, London, UK.ORCID https://orcid.org/0000-0002-8054-2293
Stephen JollesImmunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, UK.
Olivia LamersDept of Parasitology, Leiden University Medical Center, Leiden, The Netherlands.
Anne BergeronUniversité de Paris, Hôpital Saint-Louis, AP-HP, Pulmonology Dept, Paris, France.
Marion MalphettesImmunology Dept, Inserm U1126, Hôpital Saint-Louis, APHP, Paris, France.
Véronique MeigninDept of Pathology, Hôpital Saint-Louis, APHP, Paris, France.
Cinzia MilitoDept of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
Tomas MilotaSecond Faculty of Medicine, Charles University, Prague, Czech Republic.
Martine PergentInternational Patient Organisation for Primary Immunodeficiencies, Brussels, Belgium.
Antje PrasseDept of Pulmonology, Hannover Medical School, Hannover, Germany.ORCID https://orcid.org/0000-0002-7336-7458
Isabella QuintiDept of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
Elisabetta RenzoniInterstitial Lung Disease Unit, Royal Brompton Hospital/Imperial College London, London, UK.
Anna SedivaSecond Faculty of Medicine, Charles University, Prague, Czech Republic.
Daiana StolzUniversity Hospital Basel, Clinic of Respiratory Medicine and Pulmonary Cell Research, Basel, Switzerland.
Bas SmitsDept of Pediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital, UMC Utrecht, Utrecht, The Netherlands.
Friedolin Straussdsai e.V. Patientenorganisation fuer angeborene Immundefekte, Schnaitsee, Germany.
Annick A J M van de VenDept of Internal Medicine and Allergology, University Medical Centre Groningen, Groningen, The Netherlands.
Joris van MontfransDept of Internal Medicine and Allergology, University Medical Centre Groningen, Groningen, The Netherlands.
Klaus WarnatzDept of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Funding

Wellcome Trust 209553/Z/17/Z
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34881327
PMCPMC8646000

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.